9–12 May 2006
Palais du Pharo, Marseille
Europe/Zurich timezone

Monitoring of Tumor Growth and Metastasis Potential in MDA-MB-435s-tk/luc Human Breast Cancer Xenografts

12 May 2006, 09:45
15m
Palais du Pharo, Marseille

Palais du Pharo, Marseille

oral S9_S10 Molecular Imaging Molecular Imaging

Speaker

Ms Ya-Fang Chang (Institute of Radiological Sciences, National Yang-Ming University, Taipei, Taiwan)

Description

Recently, molecular imaging of reporter gene expression provides a rapid, sensitive, and noninvasive monitoring of tumor behaviors. In this study, we reported the establishment of novel animal models using immunodeficient mice for longitudinal examination of tumor growth kinetics and metastatic spreading in vivo. The highly metastatic MDA-MB-435s cell line was engineered to stably expressed herpes simplex virus type 1 thymidine kinase (HSV-1-tk) and luciferase. Both 131I- FIAU and D-luciferin were used as probes. For orthotopic tumor formation, MDA-MB- 435s-tk/luc cells were implanted into the first nipple of 6-week-old female NOD/SCID mice. For metastatic study, cells were injected via the lateral tail vein. Mice bearing MDA-MB-435s-tk/luc tumors were imaged for tumor growth and metastatic sites using Xenogen IVIS50 bioluminescent system. Gamma scintigraphy, whole-body autoradiography were also applied to confirm the localization. The result of bioluminescent imaging showed that distinct photon accumulation could be detected and quantified in the femur, spine, spleen, salivary gland, lymph nodes, and muscle at 16 weeks post i.v. injection. Histopathological examination further verified tumor metastasis at those organs as well. We concluded that establishment of MDA-MB- 435s-tk/luc human breast carcinoma-bearing mouse model combined with multimodalities of molecular imaging can facilitate studies on the molecular mechanisms behind invasion and metastasis, and also allow a more convenient, sensitive and noninvasive imaging protocol for the diagnosis of the diseases as well as for the evaluation of therapeutic efficacy of newly developed drugs or new treatment trial in preclinical studies.

Authors

Prof. Jeng-Jong Hwang (Institute of Radiological Sciences, National Yang-Ming University, Taipei, Taiwan) Ms Ya-Fang Chang (Institute of Radiological Sciences, National Yang-Ming University, Taipei, Taiwan)

Co-authors

Prof. Fei Pang (Dept. of Veterinary Medicine, National Taiwan University, Taipei, Taiwan) Prof. Hsin-Ell Wang (Institute of Radiological Sciences, National Yang-Ming University, Taipei, Taiwan) Dr Ren-Shen Liu (Dept. of Nuclear Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan) Mr Yi-Yu Lin (Institute of Radiological Sciences, National Yang-Ming University, Taipei, Taiwan)

Presentation materials

There are no materials yet.